Gastric Myeloid Sarcoma.
| Autor: | Shaikh AS; Department of Gastroenterology, Hepatology, and Nutrition, University of Texas MD Anderson Cancer Center, Houston, TX., Almanza Huante E; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX., Taherian M; Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, TX., Quesada AE; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX., Jabbour EJ; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX., Thirumurthi S; Department of Gastroenterology, Hepatology, and Nutrition, University of Texas MD Anderson Cancer Center, Houston, TX. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | ACG case reports journal [ACG Case Rep J] 2023 Sep 05; Vol. 10 (9), pp. e01137. Date of Electronic Publication: 2023 Sep 05 (Print Publication: 2023). |
| DOI: | 10.14309/crj.0000000000001137 |
| Abstrakt: | Most gastric cancers are adenocarcinomas, but other malignancies can arise in the stomach. Patients with leukemia may develop myeloid sarcoma (MS) in the gastrointestinal tract. Our patient was a 68-year-old woman who was initially diagnosed with acute myeloid leukemia and underwent a matched unrelated stem cell transplantation. She was in remission for 10 years before developing a rare case of gastric MS without acute myeloid leukemia. She had partial response to chemotherapy but ultimately died because of infection. Gastric MS has an incidence of less than 1%. Gastrointestinal involvement usually involves the small intestine and rarely the stomach. (© 2023 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of The American College of Gastroenterology.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|